Burson chosen to direct strategy for Pfizer's Pregabalin
NEW YORK: Pfizer has appointed Burson-Marsteller to handle US and international strategy for Pregabalin, a treatment for neuropathic pain and adjunctive therapy in epilepsy, which is currently pending review in the US and in Europe.
Sign in to continue
Need to activate your subscription?
Domain/Group Subscriptions
Click here >>
Individual Subscriptions
Click here >>
Need to activate your Subscription
Company Wide Subscriptions
Click here >>
UK Individual Subscribers
Click here >>